Tapani Viitala

Group Name: Pharmaceutical Biophysics

Subject: Pharmacy

University: Åbo Akademi University

AboCRIS Profile: link

Areas of Expertise

NAP4DIVE: Non-Animal Platform for Nanoparticle-Based Delivery Across the Blood-Brain Barrier Interface with Vehicle Evolution - EU Horizon RIA
Nordic Pharmaceutical Translation and Innovation - Nordforsk
MADNESS: Centre of Excellence in Materials-driven solutions for combating antimicrobial resistance - Åbo Akademi Foundation
Data integrated platforms for the design, production, and testing of therapeutics (project in Helsinki) - Business Finland

Semi-solid extruded tablets for personalized pediatric use: Development, Quality control and In-Vitro Assessment of Enteral Tube Administration. European Journal of Pharmaceutical Sciences. 2025. DOI: 10.1016/j.ejps.2025.107122
Monitoring silica core@shell nanoparticle-bacterial film interactions using the multi-parametric surface plasmon resonance technique. Smart Medicine 2. 2023. DOI: 10.1002/SMMD.20230012
In Vitro Characterization and Real-Time Label-Free Assessment of the Interaction of Chitosan-Coated Niosomes with Intestinal Cellular Monolayers. Langmuir. 2023. DOI: 10.1021/acs.langmuir.3c00728
Protein A/G-based surface plasmon resonance biosensor for regenerable antibody-mediated capture and analysis of nanoparticles. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2022. DOI: 10.1016/j.colsurfa.2022.130015
In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow. Nanoscale. 2020. DOI: 10.1039/C9NR08186K